XML 62 R49.htm IDEA: XBRL DOCUMENT v3.25.1
ACQUISITIONS, DIVESTITURES AND STRATEGIC INVESTMENTS - Additional Information (Details) - USD ($)
3 Months Ended 12 Months Ended
Apr. 01, 2024
Dec. 12, 2023
Jun. 29, 2024
Mar. 29, 2025
Mar. 30, 2024
Apr. 01, 2023
Business Acquisition [Line Items]            
Acquisitions       $ 150,906,000 $ 243,852,000 $ 2,850,000
Term loan borrowings       250,000,000 0 280,000,000
Goodwill       604,269,000 565,082,000 466,231,000
Gain (Loss) on Investments       0 $ 0 0
Convertible Senior Notes Due 2026 | Level 2            
Business Acquisition [Line Items]            
Convertible Debt, Fair Value Disclosures       286,300,000    
Convertible Senior Notes Due 2029 | Level 2            
Business Acquisition [Line Items]            
Convertible Debt, Fair Value Disclosures       $ 668,400,000    
Attune Medical            
Business Acquisition [Line Items]            
Business combination, consideration transferred $ 187,700,000          
Payments to Acquire Businesses, Gross 162,000,000          
Acquisitions 150,500,000          
Business Combination, Contingent Consideration, Liability 25,300,000          
Goodwill 70,256,000          
Deferred tax liability $ 26,155,000          
Attune Medical | Selling, general and administrative expenses            
Business Acquisition [Line Items]            
Business Combination, Acquisition Related Costs     $ 9,800,000      
OpSens, Inc.            
Business Acquisition [Line Items]            
Payments to Acquire Businesses, Gross   $ 254,500,000        
Acquisitions   243,900,000        
Goodwill   79,400,000        
Deferred tax liability   $ 14,805,000        
Business Combination, Separately Recognized Transactions, Additional Disclosures, Acquisition Cost Expensed           $ 6,600,000